{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:19:15Z","timestamp":1794745155371,"version":"4.9.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019125","name":"National Institute of Pharmaceutical Education and Research, Ahmedabad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EM\/Dev\/SG\/171\/0227\/2023"],"award-info":[{"award-number":["EM\/Dev\/SG\/171\/0227\/2023"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.biopha.2026.119984","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:12:28Z","timestamp":1791810748000},"page":"119984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dual targeting of cytochrome bd and bc1-aa3 terminal oxidases eradicates phenotypically diverse population of Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3006-7997","authenticated-orcid":false,"given":"Arnab","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashikanta","family":"Sau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja Kumari","family":"Agnivesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishan Kumar","family":"Parida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4346-6567","authenticated-orcid":false,"given":"Nitin Pal","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119984_bib1","unstructured":"World Health Organization, Global Tuberculosis Report, 2025. https:\/\/doi.org\/978 92 4 156450 2."},{"key":"10.1016\/j.biopha.2026.119984_bib2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"Barry","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biopha.2026.119984_bib3","doi-asserted-by":"crossref","first-page":"40174","DOI":"10.1074\/jbc.M406796200","article-title":"The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action","volume":"279","author":"Boshoff","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119984_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.02339","article-title":"Hypoxic non-replicating persistent mycobacterium tuberculosis develops thickened outer layer that helps in restricting rifampicin entry","volume":"10","author":"Jakkala","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2026.119984_bib5","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1128\/iai.64.6.2062-2069.1996","article-title":"An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence","volume":"64","author":"Wayne","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biopha.2026.119984_bib6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nri3211","article-title":"Revisiting the role of the granuloma in tuberculosis","volume":"12","author":"Ramakrishnan","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2026.119984_bib7","first-page":"1","article-title":"Targeting bacterial energetics to produce new antimicrobials","volume":"36","author":"Hards","year":"2018","journal-title":"Drug. Resist. Updat. Rev. Comment. Antimicrob. Anticancer. Chemother."},{"key":"10.1016\/j.biopha.2026.119984_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MGM2-0015-2013","article-title":"Energetics of respiration and oxidative phosphorylation in mycobacteria","volume":"2","author":"Cook","year":"2014","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.biopha.2026.119984_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008614","article-title":"Unique flexibility in energy metabolism allows mycobacteria to combat starvation and hypoxia","volume":"5","author":"Berney","year":"2010","journal-title":"PLoS. One"},{"issue":"80-.","key":"10.1016\/j.biopha.2026.119984_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119984_bib11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nchembio884","article-title":"Diarylquinolines target subunit c of mycobacterial ATP synthase","volume":"3","author":"Koul","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biopha.2026.119984_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/2229-516X.112228","article-title":"Bedaquiline: first FDA-approved tuberculosis drug in 40 years","volume":"3","author":"Mahajan","year":"2013","journal-title":"Int. J. Appl. Basic. Med. Res."},{"key":"10.1016\/j.biopha.2026.119984_bib13","doi-asserted-by":"crossref","first-page":"25273","DOI":"10.1074\/jbc.M803899200","article-title":"Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis","volume":"283","author":"Koul","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119984_bib14","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/jac\/dkv054","article-title":"Bactericidal mode of action of bedaquiline","volume":"70","author":"Hards","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2026.119984_bib15","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1021\/acsinfecdis.4c00710","article-title":"2-Aryl-Benzoimidazoles as Type II NADH Dehydrogenase Inhibitors of Mycobacterium tuberculosis","volume":"10","author":"Saha","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.biopha.2026.119984_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1021\/acsinfecdis.5b00154","article-title":"Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: potent anti-tuberculosis agents that target QcrB","volume":"2","author":"Moraski","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.biopha.2026.119984_bib17","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nm.3262","article-title":"Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis","volume":"19","author":"Pethe","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2026.119984_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02661-18","article-title":"Novel MenA inhibitors are bactericidal against mycobacterium tuberculosis and synergize with electron transport chain inhibitors","volume":"63","author":"Berube","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2026.119984_bib19","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1056\/NEJMc1913327","article-title":"Telacebec (Q203), a new antituberculosis agent","volume":"382","author":"de Jager","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119984_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12393","article-title":"Turning the respiratory flexibility of Mycobacterium tuberculosis against itself","volume":"7","author":"Lamprecht","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119984_bib21","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1038\/s41598-018-20989-8","article-title":"The anti-mycobacterial activity of the cytochrome bcc inhibitor Q203 can be enhanced by small-molecule inhibition of cytochrome bd","volume":"8","author":"Lu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119984_bib22","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1073\/pnas.1706139114","article-title":"Exploiting the synthetic lethality between terminal respiratory oxidases to kill Mycobacterium tuberculosis and clear host infection","volume":"114","author":"Kalia","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2026.119984_bib23","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001695","article-title":"Unravelling the flexibility of Mycobacterium tuberculosis: an escape way for the bacilli","volume":"72","author":"Sau","year":"2023","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.biopha.2026.119984_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01338-17","article-title":"Susceptibility of Mycobacterium tuberculosis cytochrome bd oxidase mutants to compounds targeting the terminal respiratory oxidase, cytochrome c","volume":"61","author":"Moosa","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2026.119984_bib25","doi-asserted-by":"crossref","first-page":"6962","DOI":"10.1128\/AAC.03486-14","article-title":"Respiratory flexibility in response to inhibition of cytochrome C oxidase in Mycobacterium tuberculosis","volume":"58","author":"Arora","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2026.119984_bib26","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1039\/D3MD00587A","article-title":"Cytochrome bd oxidase: an emerging anti-tubercular drug target","volume":"15","author":"Saha","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.biopha.2026.119984_bib27","article-title":"The cytochrome bd-type quinol oxidase is important for survival of Mycobacterium smegmatis under peroxide and antibiotic-induced stress","volume":"5","author":"Lu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119984_bib28","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1038\/s41467-019-13122-4","article-title":"Homologous bd oxidases share the same architecture but differ in mechanism","volume":"10","author":"The\u00dfeling","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119984_bib29","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013207","article-title":"Dual inhibition of the terminal oxidases eradicates antibiotic-tolerant Mycobacterium tuberculosis","volume":"13","author":"Lee","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biopha.2026.119984_bib30","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.bmcl.2013.02.072","article-title":"Identification and synthesis of N-(thiophen-2-yl) benzamide derivatives as BRAFV600E inhibitors","volume":"23","author":"Xie","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2026.119984_bib31","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1038\/s41467-021-25537-z","article-title":"The cryo-EM structure of the bd oxidase from M. tuberculosis reveals a unique structural framework and enables rational drug design to combat TB","volume":"12","author":"Safarian","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119984_bib32","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.aaf2477","article-title":"Structure of a bd oxidase indicates similar mechanisms for membrane-integrated oxygen reductases","volume":"352","author":"Safarian","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119984_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118323","article-title":"Inhibition of cytochrome bd oxidase in Mycobacterium tuberculosis by benzothiazole amides","volume":"129","author":"Kumar","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119984_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2026.146801","article-title":"Synthesis and biological evaluation of quinoline-8-amides as cytochrome bd oxidase inhibitors to combat respiratory flexibility in Mycobacterium tuberculosis","volume":"1375","author":"Kumar","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.biopha.2026.119984_bib35","doi-asserted-by":"crossref","first-page":"11945","DOI":"10.1073\/pnas.0711697105","article-title":"The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis","volume":"105","author":"Rao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119984_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00938-18","article-title":"Rational design of biosafety level 2-approved, multidrug-resistant strains of Mycobacterium tuberculosis through nutrient auxotrophy","volume":"9","author":"Vilch\u00e8ze","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.biopha.2026.119984_bib37","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1021\/acsinfecdis.4c00415","article-title":"Development and evaluation of bis-benzothiazoles as a new class of benzothiazoles targeting DprE1 as antitubercular agents","volume":"10","author":"Samoon","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.biopha.2026.119984_bib38","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1021\/acsinfecdis.5c01066","article-title":"Simultaneous inhibition of cytochrome bd oxidase and ATP synthase for complete eradication of mycobacterium tuberculosis","volume":"12","author":"Roy","year":"2026","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.biopha.2026.119984_bib39","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/JB.00324-13","article-title":"The Escherichia coli CydX protein is a member of the CydAB cytochrome bd oxidase complex and is required for cytochrome bd oxidase activity","volume":"195","author":"VanOrsdel","year":"2013","journal-title":"J. Bacteriol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226010206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226010206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:48:49Z","timestamp":1794743329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226010206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":39,"alternative-id":["S0753332226010206"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119984","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual targeting of cytochrome bd and bc1-aa3 terminal oxidases eradicates phenotypically diverse population of Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119984"}}